Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Total 13F shares
-
35,074,938
-
Share change
-
+14,051,361
-
Total reported value
-
$1,222,723,384
-
Price per share
-
$34.87
-
Number of holders
-
80
-
Value change
-
+$493,415,349
-
Number of buys
-
54
-
Number of sells
-
26
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q2 2019
As of 30 Jun 2019,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,074,938 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Segantii Capital Management Ltd, SC CHINA HOLDING Ltd, BAMCO INC /NY/, BAILLIE GIFFORD & CO, FEDERATED INVESTORS INC /PA/, CREDIT SUISSE AG/, ORBIMED ADVISORS LLC, and GILDER GAGNON HOWE & CO LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.